Publication:
Comparative Effectiveness of Natalizumab and Fingolimod in Different Subgroups of Patients with Relapsing-Remitting Multiple Sclerosis

Simple item page
dc.contributor.authorSharmin, S.
dc.contributor.authorLefort, M.
dc.contributor.authorAndersen, J.
dc.contributor.authorHorakova, D.
dc.contributor.authorHavrdova, E. K.
dc.contributor.authorAlroughani, R.
dc.contributor.authorLechner-Scott, J.
dc.contributor.authorIDMcCombe, Pamela/0000-0003-2704-8517
dc.contributor.authorIDTurkoglu, Recai/0000-0001-9724-851X
dc.contributor.authorIDFerraro, Diana/0000-0003-4818-3806
dc.date.accessioned2020-06-21T12:26:01Z
dc.date.available2020-06-21T12:26:01Z
dc.date.issued2019
dc.departmentOMÜen_US
dc.department-temp[Sharmin, S.] Univ Melbourne, Dept Med, CORe, Melbourne, Vic, Australia -- [Sharmin, S.] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia -- [Lefort, M. -- Leray, E.] EHESP Sch Publ Hlth, Dept Quantitat Methods Publ Hlth MeTIS, Rennes, France -- [Andersen, J. -- Sorensen, P. S. -- Sellebjerg, F.en_US
dc.description35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS -- SEP 11-13, 2019 -- Stockholm, SWEDENen_US
dc.description.abstract…en_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis, Congrex Switzerland Ltden_US
dc.description.sponsorshipTEVA Neuroscience; CIHRCanadian Institutes of Health Research (CIHR); MS Society of Canada; EMD; BiogenBiogen; NovartisNovartis; GenzymeGenzyme Corporationen_US
dc.description.sponsorshipPierre Duquette served on editorial boards and has been supported to attend meetings by EMD, Biogen, Novartis, Genzyme, and TEVA Neuroscience. He holds grants from the CIHR and the MS Society of Canada and has received funding for investigator-initiated trials from Biogen, Novartis, and Genzyme.en_US
dc.identifier.endpage788en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.startpage786en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10631
dc.identifier.volume25en_US
dc.identifier.wosWOS:000485303103217
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleComparative Effectiveness of Natalizumab and Fingolimod in Different Subgroups of Patients with Relapsing-Remitting Multiple Sclerosisen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu